Delivery Order SPE2DB22D1002-SPE2DB25FLHU5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $1,997.24 delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $1,149.20. This non-set-aside award is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) valued at $1,721.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 10 mg capsules in quantities of 100 units, with a contract ceiling value of $1,194.12. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 16, 2025. The award supports federal medical procurement needs, with performance of work occurring...
- The Defense Logistics Agency awarded a $5,384.37 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis and will be performed at the vendor's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $3,890.69 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Adderall XR 25 mg capsules (100-count units) valued at $1,828.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is expected to be completed by September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Adderall XR 5 mg capsules (100-count units) with a ceiling value of $1,083.01. This firm fixed-price delivery order is scheduled for completion by July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively without any set-aside designation. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 30 mg capsules (quantity: 100s) valued at $2,232.71. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents performance at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHU5Delivery Order
The Defense Logistics Agency awarded a $2,308.08 delivery order contract to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 18, 2025, and performance based in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad portfolio of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet federal procurement requirements and support the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/17/25 |